Health
U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…
By Reuters Staff
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very significant work with the company to figure out if theres a significant safety issue or not, FDA Commissioner Stephen H…
-
Noosa News20 hours agoTake a look behind the scenes at Noosa Arts Theatre
-
Noosa News20 hours agoWelcome for Greens homeless plan
-
General22 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails